InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Discover the detailed record of transactions filed by Connaughton Bernadette, Director. Officer active across 2 companies, notably Halozyme Therapeutics, INC.. Aggregated, 10 filings have been recorded. Total volume traded: €416k. The latest transaction was filed on 1 May 2026 — Cession. Regulator: SEC (Form 4). All data is free.
Declarations10 total
US$87,9481,625 shares@ US$54.12180.0011% mcap42.3% of flow
Common Stock
SEC:0001159036-26-000055·
€87,9481,625 shares@ €54.12180.0011% mcap21.1% of flow
Common Stock
SEC:0001159036-26-000055:0·
US$120,0382,000 shares@ US$60.01880.0015% mcap57.7% of flow
Common Stock
SEC:0001159036-26-000006·
€120,0382,000 shares@ €60.01880.0015% mcap28.9% of flow
Common Stock
SEC:0001159036-26-000006:0·
02,839 shares0
Class A Common Stock
SEC:0001209191-22-032624:0·
06,206 shares0
Restricted Stock Units
SEC:0001179110-22-002907:0·
02,364 shares0
Class A Common Stock
SEC:0001209191-21-032806·
02,364 shares0
Class A Common Stock
SEC:0001209191-21-032806:0·
5,230 shares
Restricted Stock Units
SEC:0001179110-21-004970·
05,230 shares0
Restricted Stock Units
SEC:0001179110-21-004970:0·
10 of 10 declarations
About Connaughton Bernadette
Bernadette Connaughton is a Director at Halozyme Therapeutics, Inc. and Syneos Health, Inc. She contributes to the governance of both companies and strategic decision-making. Bernadette brings her expertise in biotechnology to help guide growth initiatives.
